bluuebunny/crossref_metadata_2025 huggingface dataset:
Table S1 from An Exploration of Changes in the Measurement of Mammography in the National Health Interview Survey
Authors: Gonzales Felisa A. , Willis Gordon B. , Breen Nancy , Yan Ting , Cronin Kathy A. , Taplin Stephen H. , Yu Mandi
Published: April 2023

Results of Multinomial Regressions Showing Correlates of Two Types of Inconsistent Responses to Past Year Mammography Questions (2013), by Age Group (Adjusted)
Supplementary Tables 1-4, Figures 1-2 from Batch Effects and Pathway Analysis: Two Potential Perils in Cancer Studies Involving DNA Methylation Array Analysis
Authors: Harper Kristin N. , Peters Brandilyn A. , Gamble Mary V.
Published: April 2023

PDF File - 177K, Complete "Diseases and Disorders" results from IPA simulations.
Supplementary Figure 3 from Physical Activity and Risk of Lymphoma: A Meta-Analysis
Authors: Vermaete Nele V.H. , Wolter Pascal , Verhoef Gregor E.G. , Kollen Boudewijn J. , Kwakkel Gert , Schepers Leen , Gosselink Rik
Published: April 2023

PDF File - 49K, Figure of the conducted subgroup meta-analysis for domain of physical activity (recreational versus occupational physical activity).
Suppl Table 1 from Subsequent Primary Malignancies in Patients with Nonmelanoma Skin Cancer in England: A National Record-Linkage Study
Authors: Ong Eugene Liat Hui , Goldacre Raph , Hoang Uy , Sinclair Rodney , Goldacre Michael
Published: April 2023

Analysis by sex: observed numbers of people with NMSC who had a subsequent record of primary malignant cancer, risk ratios (RR) and 95% confidence intervals
Supplementary Table 1 from Human Papillomavirus Load in Eyebrow Hair Follicles and Risk of Cutaneous Squamous Cell Carcinoma
Authors: Neale Rachel E. , Weissenborn Soenke , Abeni Damiano , Bavinck Jan Nico Bouwes , Euvrard Sylvie , Feltkamp Mariet C.W. , Green Adele C. , Harwood Catherine , de Koning Maurits , Naldi Luigi , Nindl Ingo , Pawlita Michael , Proby Charlotte , Quint Wim G. , Waterboer Tim , Wieland Ulrike , Pfister Herbert
Published: April 2023

PDF file - 45K, Associations between cumulative HPV load and SCC, stratified by skin type and time since transplantation (for OTR). In each case the reference category is HPV negative combined with the lowest load tertile.
Supplemental Tables from MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium
Authors: Drahos Jennifer , Schwameis Katrin , Orzolek Linda D. , Hao Haiping , Birner Peter , Taylor Phillip R. , Pfeiffer Ruth M. , Schoppmann Sebastian F. , Cook Michael B.
Published: April 2023

Supplemental Table 1: Patient clinical and demographic characteristics. Supplemental Table 2: miRNAs differentially detected among esophageal adenocarcinoma and Barrett's esophagus. Supplemental Table 3: miRNAs differentially expressed among esophageal adenocarcinoma and Barrett's esophagus. Supplemental Table 4: miRNAs differentially expressed among esophageal adenocarcinoma and Barrett's esophagus. Supplemental Table 5: miRNAs differentially detected among early-stage (T1b & T2) esophageal adenocarcinoma and Barrett's esophagus. Supplemental Table 6: miRNAs differentially expressed among early-stage esophageal adenocarcinoma (T1b & T2) and Barrett's esophagus. Supplemental Table 7. Areas Under Receiver Operating Characteristic Curves of Pairwise miR Models Using Five-Fold Cross-Validation. Supplemental Table 8: Summary of published associations between significant top miRNAs and cancer.
Supplementary Table 4 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Authors: Kruzikas Denise , Smith Jennifer S. , Harley Carolyn , Buzinec Paul
Published: April 2023

PDF file, 58K, Appendix Table D: Median (Mean SD) Cost Per Procedure, 2001-2006, by Age Group.
Supplementary Table 3 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Authors: Kruzikas Denise , Smith Jennifer S. , Harley Carolyn , Buzinec Paul
Published: April 2023

PDF file, 12K, Appendix Table C: Procedure Rates Among Target Age Groups.
Supplementary Tables 1 through 4 and Supplementary Figures 1 through 3 from Genetic Variation in Prostate-Specific Antigen–Detected Prostate Cancer and the Effect of Control Selection on Genetic Association Studies
Authors: Knipe Duleeka W. , Evans David M. , Kemp John P. , Eeles Rosalind , Easton Douglas F. , Kote-Jarai Zsofia , Al Olama Ali Amin , Benlloch Sara , Donovan Jenny L. , Hamdy Freddie C. , Neal David E. , Davey Smith George , Lathrop Mark , Martin Richard M.
Published: April 2023

PDF - 207K, Supplementary Table 1 - Characteristics of 1146 cases and 1804 controls included in the ProtecT GWAS. Supplementary Table 2:381 SNPs associated with PrCa with P<5 x 10-5 in the ProtecT GWAS. Supplementary Table 3 - Association of SNPs with prostate cancer using low PSA controls in ProtecT for SNPs with moderate-high levels of heterogeneity* and metaanalysis of the results with UKGPCS, 14 Supplementary Table 4 - Comparison of cases with low (PSA <0.05ng/ml) and high (PSA ≥2 ng/ml) PSA controls(sensitivity analysis)*. Supplementary Figure 1 - Quantile-quantile plot (Q-Q plot) for ProtecT GWAS, Supplementary Figure 2 - Manhattan Plot for ProtecT GWAS. Supplementary Figure 3 - Locus Zoom2 plot of region 10q11.23 of the ProtecT GWAS.
Supplemental Table 4. 3-year lag analysis from Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims (“MedWAS”)
Authors: Engels Eric A. , Parsons Ruth , Besson Caroline , Morton Lindsay M. , Enewold Lindsey , Ricker Winnie , Yanik Elizabeth L. , Arem Hannah , Austin April A. , Pfeiffer Ruth M.
Published: April 2023

3-year lag analysis
Supplemental Material (for review only) File - Supplementary Tables 1-5. from Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid
Authors: Castells Xavier , Karanović Sandra , Ardin Maude , Tomić Karla , Xylinas Evanguelos , Durand Geoffroy , Villar Stephanie , Forey Nathalie , Le Calvez-Kelm Florence , Voegele Catherine , Karlović Krešimir , Mišić Maja , Dittrich Damir , Dolgalev Igor , McKay James , Shariat Shahrokh F. , Sidorenko Viktoria S. , Fernandes Andrea , Heguy Adriana , Dickman Kathleen G. , Olivier Magali , Grollman Arthur P. , Jelaković Bojan , Zavadil Jiri
Published: April 2023

Supplementary Table S1: Clinicopathological and epidemiological patient data and urothelial tumor sample description. Supplementary Table S2: Complete list of annotated SBS identified in all LC-WES analyzed urothelial tumors (HiSeq2500 data only). Supplementary Table S3: GO and KEGG Classification of genes mutated by non-synonymous A:T>T:A mutations. Supplementary Table S4: List of cancer driver genes found recurrently mutated in the EN and Taiwan UTUC sample sets. Supplementary Table S5: GO and KEGG classification of the recurrently mutated cancer driver genes (see Figure 3B).
Supplementary Table 5 from Tissue Biomarkers for Prognosis of Prostate Cancer: A Systematic Review and Meta-analysis
Authors: Zhao Liuyang , Yu Na , Guo Tianfang , Hou Yixuan , Zeng Zongyue , Yang Xiaorong , Hu Ping , Tang Xi , Wang Jian , Liu Manran
Published: April 2023

PDF file - 76KB, Supplementary Table S5. Proteins of the eligible studies related to PSM organized according to Hanahan-Weinberg functional capabilities.
Table S 1 from Rural–Urban Differences in Cancer Incidence and Trends in the United States
Authors: Zahnd Whitney E. , James Aimee S. , Jenkins Wiley D. , Izadi Sonya R. , Fogleman Amanda J. , Steward David E. , Colditz Graham A. , Brard Laurent
Published: April 2023

Supplementary Table 1: Cancer Incidence Rates by U.S. Census Region and Race/Ethnicity
Supplementary Table 2 from Tissue Biomarkers for Prognosis of Prostate Cancer: A Systematic Review and Meta-analysis
Authors: Zhao Liuyang , Yu Na , Guo Tianfang , Hou Yixuan , Zeng Zongyue , Yang Xiaorong , Hu Ping , Tang Xi , Wang Jian , Liu Manran
Published: April 2023

XLSX file - 16KB, Supplementary Table S2. Summary of 20 cohort studies without HR(95 percent CI).
Supplementary Figure 1B from Tissue Biomarkers for Prognosis of Prostate Cancer: A Systematic Review and Meta-analysis
Authors: Zhao Liuyang , Yu Na , Guo Tianfang , Hou Yixuan , Zeng Zongyue , Yang Xiaorong , Hu Ping , Tang Xi , Wang Jian , Liu Manran
Published: April 2023

PDF file - 394KB, Supplementary Figure 1. Forest plots of the data from the eligible studies in comparison of the outcome with each of the fourteen biomarkers (labeled A through N). The biomarkers were pooled with two or more studies using both fixed effects and random effects model. Of these studies, hazard ratio (HR), 95 percent confidence interval (CI) and relative weight are displayed, respectively. SEs are displayed for log of the HR.
supplemental table 2 from Association between Upper Digestive Tract Microbiota and Cancer-Predisposing States in the Esophagus and Stomach
Authors: Yu Guoqin , Gail Mitchell H. , Shi Jianxin , Klepac-Ceraj Vanja , Paster Bruce J. , Dye Bruce A. , Wang Guo-Qing , Wei Wen-Qiang , Fan Jin-Hu , Qiao You-Lin , Dawsey Sanford M. , Freedman Neal D. , Abnet Christian C.
Published: April 2023

Odds ratio and 95% confidence intervals for the associations between presence/absence of individual strain/species and PGI/II ratio
Supplementary Table 2 from Serum Vascular Adhesion Protein-1 Level Predicts Risk of Incident Cancers in Subjects with Type II Diabetes
Authors: Yu Tse-Ya , Li Hung-Yuan , Jiang Yi-Der , Chang Tien-Jyun , Wei Jung-Nan , Lin Chi-Ming , Chu Ching-Chi , Chuang Lee-Ming
Published: April 2023

PDF - 64K, HRs (95% CI) for incident cancers excluding subjects with shorter follow-up time.
Supplementary Information 1 from Prevalidation of Salivary Biomarkers for Oral Cancer Detection
Authors: Elashoff David , Zhou Hui , Reiss Jean , Wang Jianghua , Xiao Hua , Henson Bradley , Hu Shen , Arellano Martha , Sinha Uttam , Le Anh , Messadi Diana , Wang Marilene , Nabili Vishad , Lingen Mark , Morris Darly , Randolph Timothy , Feng Ziding , Akin David , Kastratovic Dragana A. , Chia David , Abemayor Elliot , Wong David T.W.
Published: April 2023

PDF file - 65K
Supplementary Figure 1 from Serum Vascular Adhesion Protein-1 Level Predicts Risk of Incident Cancers in Subjects with Type II Diabetes
Authors: Yu Tse-Ya , Li Hung-Yuan , Jiang Yi-Der , Chang Tien-Jyun , Wei Jung-Nan , Lin Chi-Ming , Chu Ching-Chi , Chuang Lee-Ming
Published: April 2023

PDF - 78K, Cumulative incidence function (CIF) of cancer among subgroups (A) stratified by tertile of serum VAP-1 (B) stratified by the presence of chronic kidney disease.
Supplementary Material 4 from Organizational Predictors of Colonoscopy Follow-up for Positive Fecal Occult Blood Test Results: An Observational Study
Authors: Partin Melissa R. , Burgess Diana J. , Burgess James F. , Gravely Amy , Haggstrom David , Lillie Sarah E. , Nugent Sean , Powell Adam A. , Shaukat Aasma , Walter Louise C. , Nelson David B.
Published: April 2023

Supplementary Material 4. Methods used to identify and adjust for reasons for not completing a colonoscopy.
Supplementary Figure 4 from Maternal Smoking and DNA Methylation in Newborns: In Utero Effect or Epigenetic Inheritance?
Authors: Joubert Bonnie R. , Håberg Siri E. , Bell Douglas A. , Nilsen Roy M. , Vollset Stein Emil , Midttun Øivind , Ueland Per Magne , Wu Michael C. , Nystad Wenche , Peddada Shyamal D. , London Stephanie J.
Published: April 2023

PDF - 225K, Evaluation of the additional effect of grandmother smoking on DNA methylation at the 26 CpGs of interest, given the mother smoked in her pregnancy. Each point represents the association for each CpG in each category. *Significance threshold p<0.0019 (below the line is not statistically significant).
Supplementary Figure 2 from Maternal Smoking and DNA Methylation in Newborns: In Utero Effect or Epigenetic Inheritance?
Authors: Joubert Bonnie R. , Håberg Siri E. , Bell Douglas A. , Nilsen Roy M. , Vollset Stein Emil , Midttun Øivind , Ueland Per Magne , Wu Michael C. , Nystad Wenche , Peddada Shyamal D. , London Stephanie J.
Published: April 2023

PDF - 80K, Association between the timing of mother smoking (before and during pregnancy) and DNA methylation at 26 CpGs of interest. Each point represents the association for each CpG in each smoking category. *Significance threshold p<0.0019 (below the line is not statistically significant).
Supplementary Table S1 from Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans
Authors: Pine Sharon R. , Mechanic Leah E. , Enewold Lindsey , Bowman Elise D. , Ryan Bríd M. , Cote Michele L. , Wenzlaff Angela S. , Loffredo Christopher A. , Olivo-Marston Susan , Chaturvedi Anil , Caporaso Neil E. , Schwartz Ann G. , Harris Curtis C.
Published: April 2023

Supplementary Table S1. Concordance between blinded, randomized duplicates and average serum cytokine limits of detection
Supplementary Tables 1A - 1G from Physical Activity in Relation to Risk of Hematologic Cancers: A Systematic Review and Meta-analysis
Authors: Jochem Carmen , Leitzmann Michael F. , Keimling Marlen , Schmid Daniela , Behrens Gundula
Published: April 2023

PDF file - 94KB, Supplementary Table S1a. Physical activity and non-Hodgkin lymphoma. Summary risk estimates from random-effects models including 23 risk estimates, stratified by selected study characteristics. Supplementary Table S1b. Physical activity and Hodgkin lymphoma. summary risk estimates from random-effects models including 6 risk estimates, stratified by selected study characteristics. Supplementary Table S1c. Physical activity and follicular lymphoma. summary risk estimates from random-effects models including 9 risk estimates, stratified by selected study characteristics. Supplementary Table S1d. Physical activity and diffuse large B-cell lymphoma. summary risk estimates from random-effects models including 9 risk estimates, stratified by selected study characteristics. Supplementary Table S1e. Physical activity and leukemia. summary risk estimates from random-effects models including 9 risk estimates, stratified by selected study characteristics. Supplementary Table S1f. Physical activity and chronic lymphocytic lymphoma/small lymphocytic lymphoma. summary risk estimates from random-effects models including 7 risk estimates, stratified by selected study characteristics. Supplementary Table S1g. Physical activity and multiple myeloma. summary risk estimates from random-effects models including 12 risk estimates, stratified by selected study characteristics.
Supplementary Figure 1 from Physical Activity in Relation to Risk of Hematologic Cancers: A Systematic Review and Meta-analysis
Authors: Jochem Carmen , Leitzmann Michael F. , Keimling Marlen , Schmid Daniela , Behrens Gundula
Published: April 2023

PDF file - 50KB, Flowchart of PubMed literature search results.
Participant and Clinical Information Form from Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease
Authors: Marks Jeffrey R. , Anderson Karen S. , Engstrom Paul , Godwin Andrew K. , Esserman Laura J. , Longton Gary , Iversen Edwin S. , Mathew Anu , Patriotis Christos , Pepe Margaret S.
Published: April 2023

Participant and Clinical Information Form. Study forms used to obtain subject and clinical information.
Supplementary Methods, Tables 1-5, Figures 1-4 from Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case–Control Studies
Authors: Davies John R. , Chang Yu-mei , Bishop D. Timothy , Armstrong Bruce K. , Bataille Veronique , Bergman Wilma , Berwick Marianne , Bracci Paige M. , Elwood J. Mark , Ernstoff Marc S. , Green Adele , Gruis Nelleke A. , Holly Elizabeth A. , Ingvar Christian , Kanetsky Peter A. , Karagas Margaret R. , Lee Tim K. , Le Marchand Loïc , Mackie Rona M. , Olsson Håkan , Østerlind Anne , Rebbeck Timothy R. , Reich Kristian , Sasieni Peter , Siskind Victor , Swerdlow Anthony J. , Titus Linda , Zens Michael S. , Ziegler Andreas , Gallagher Richard P. , Barrett Jennifer H. , Newton-Bishop Julia
Published: April 2023

Supplementary Methods, Tables 1-5, Figures 1-4. Contains additional Methods and Materials on the coding of variables in the risk model, recruitment of cases to the Leeds Case-Control study, imputation, comparing self reported and nurse derived mole counts and calculations for estimating absolute risk. Contains Tables 1-5 on missingness of pooled data, risk assessment for the Leeds dataset including imputed cases, comparisons of self classification and nurse classification of mole count/freckling in the Leeds controls. Contains Figures 1-4 showing the distribution of risk scores in the pooled and Leeds data, a bland-altman plot comparing nurse and self assessment of mole count on the back in Leeds controls and a cartoon used in the Leeds Case-Control study to determine mole count.
Supplementary Tables from Age at Menarche and Late Adolescent Adiposity Associated with Mammographic Density on Processed Digital Mammograms in 24,840 Women
Authors: Alexeeff Stacey E. , Odo Nnaemeka U. , Lipson Jafi A. , Achacoso Ninah , Rothstein Joseph H. , Yaffe Martin J. , Liang Rhea Y. , Acton Luana , McGuire Valerie , Whittemore Alice S. , Rubin Daniel L. , Sieh Weiva , Habel Laurel A.
Published: April 2023

Supplementary Table 1. Relationship of square-root transformed percent density to age at menarche and late adolescent BMI; Supplementary Table 2. Relationship of cube-root transformed dense area to age at menarche and late adolescent BMI ;Supplementary Table 3. Effect modification by menopause of the associations of late adolescent BMI with percent density and dense area.
Supplementary Table 1 from Long-Term Effects of Weight Loss and Exercise on Biomarkers Associated with Angiogenesis
Authors: Duggan Catherine , Tapsoba Jean de Dieu , Wang Ching-Yun , Schubert Karen E. Foster , McTiernan Anne
Published: April 2023

Effect modification of weight loss on the long-term effect of diet on the log-transformed (normalized) biomarkers
Supplementary Figure 2 from Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase
Authors: Yang Ju Dong , Dai Jianliang , Singal Amit G. , Gopal Purva , Addissie Benyam D. , Nguyen Mindie H. , Befeler Alex S. , Reddy K. Rajender , Schwartz Myron , Harnois Denise M. , Yamada Hiroyuki , Gores Gregory J. , Feng Ziding , Marrero Jorge A. , Roberts Lewis R.
Published: April 2023

Supplementary Figure 2. The ROC of AFP for HCC diagnosis per ALT in validation cohort patients with HCV etiology
Supplementary Table 3 from TGF-β Signaling Pathway and Breast Cancer Susceptibility
Authors: Scollen Serena , Luccarini Craig , Baynes Caroline , Driver Kristy , Humphreys Manjeet K. , Garcia-Closas Montserrat , Figueroa Jonine , Lissowska Jolanta , Pharoah Paul D. , Easton Douglas F. , Hesketh Robin , Metcalfe James C. , Dunning Alison M.
Published: April 2023

Supplementary Table 3 from TGF-β Signaling Pathway and Breast Cancer Susceptibility
Supplementary Figure S2 from Prediagnostic Calcium Intake and Lung Cancer Survival: A Pooled Analysis of 12 Cohort Studies
Authors: Yu Danxia , Takata Yumie , Smith-Warner Stephanie A. , Blot William , Sawada Norie , White Emily , Freedman Neal , Robien Kim , Giovannucci Edward , Zhang Xuehong , Park Yikyung , Gao Yu-Tang , Chlebowski Rowan T. , Langhammer Arnulf , Yang Gong , Severi Gianluca , Manjer Jonas , Khaw Kay-Tee , Weiderpass Elisabete , Liao Linda M. , Caporaso Neil , Krokstad Steinar , Hveem Kristian , Sinha Rashmi , Ziegler Regina , Tsugane Shoichiro , Xiang Yong-Bing , Johansson Mattias , Zheng Wei , Shu Xiao-Ou
Published: April 2023

Forest plot of the hazard ratios of lung cancer survival in low vs. recommended dietary calcium intake
Supplementary Table 3 from Influence of Quercetin-Rich Food Intake on microRNA Expression in Lung Cancer Tissues
Authors: Lam Tram K. , Shao Stephanie , Zhao Yingdong , Marincola Francesco , Pesatori Angela , Bertazzi Pier Alberto , Caporaso Neil E. , Wang Ena , Landi Maria Teresa
Published: April 2023

PDF file - 47K, Food groups and individual food items
Supplementary Table 1 from Eighteen Insulin-like Growth Factor Pathway Genes, Circulating Levels of IGF-I and Its Binding Protein, and Risk of Prostate and Breast Cancer
Authors: Gu Fangyi , Schumacher Fredrick R. , Canzian Federico , Allen Naomi E. , Albanes Demetrius , Berg Christine D. , Berndt Sonja I. , Boeing Heiner , Bueno-de-Mesquita H. Bas , Buring Julie E. , Chabbert-Buffet Nathalie , Chanock Stephen J. , Clavel-Chapelon Françoise , Dumeaux Vanessa , Gaziano J. Michael , Giovannucci Edward L. , Haiman Christopher A. , Hankinson Susan E. , Hayes Richard B. , Henderson Brian E. , Hunter David J. , Hoover Robert N. , Johansson Mattias , Key Timothy J. , Khaw Kay-Tee , Kolonel Laurence N. , Lagiou Pagona , Lee I-Min , LeMarchand Loic , Lund Eiliv , Ma Jing , Onland-Moret N. Charlotte , Overvad Kim , Rodriguez Laudina , Sacerdote Carlotta , Sánchez Maria-José , Stampfer Meir J. , Stattin Pär , Stram Daniel O. , Thomas Gilles , Thun Michael J. , Tjønneland Anne , Trichopoulos Dimitrios , Tumino Rosario , Virtamo Jarmo , Weinstein Stephanie J. , Willett Walter C. , Yeager Meredith , Zhang Shumin M. , Kaaks Rudolf , Riboli Elio , Ziegler Regina G. , Kraft Peter
Published: April 2023

Supplementary Table 1 from Eighteen Insulin-like Growth Factor Pathway Genes, Circulating Levels of IGF-I and Its Binding Protein, and Risk of Prostate and Breast Cancer
Supplementary Materials and Methods from Polymorphisms of a Disintegrin and Metalloproteinase with Thrombospondin Motifs 5 and Aflatoxin B1–Related Hepatocellular Carcinoma
Authors: Huang Xiao-Ying , Yao Jin-Guang , Huang Bing-Chen , Ma Yun , Xia Qiang , Long Xi-Dai
Published: April 2023

Supplementary Materials and Methods
Supplementary Figure 1 from Usefulness of Saliva Samples for Biomarker Studies in Radiation Research
Authors: Pernot Eileen , Cardis Elisabeth , Badie Christophe
Published: April 2023

Supplementary Figure 1 - Search strategy for identification of studies on salivary biomarkers of exposure, susceptibility and effect relevant for ionizing radiation research.
Supplementary Figure 1 from Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk
Authors: MacInnis Robert J. , Schmidt Daniel F. , Makalic Enes , Severi Gianluca , FitzGerald Liesel M. , Reumann Matthias , Kapuscinski Miroslaw K. , Kowalczyk Adam , Zhou Zeyu , Goudey Benjamin , Qian Guoqi , Bui Quang M. , Park Daniel J. , Freeman Adam , Southey Melissa C. , Al Olama Ali Amin , Kote-Jarai Zsofia , Eeles Rosalind A. , Hopper John L. , Giles Graham G.
Published: April 2023

Plot of the first two principal components for the 7,920 participants in the iCOGS dataset.
Supplementary Table S5 from Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium
Authors: Toth Reka , Scherer Dominique , Kelemen Linda E. , Risch Angela , Hazra Aditi , Balavarca Yesilda , Issa Jean-Pierre J. , Moreno Victor , Eeles Rosalind A. , Ogino Shuji , Wu Xifeng , Ye Yuanqing , Hung Rayjean J. , Goode Ellen L. , Ulrich Cornelia M.
Published: April 2023

Summary of candidate genes with identified risk associations, chromosomal region, previously through GWAS identified risk associations in these regions and list of additional genes located in the selected regions.
Supplementary File S7 from MicroRNA Classifier and Nomogram for Metastasis Prediction in Colon Cancer
Authors: Goossens-Beumer Inès J. , Derr Remco S. , Buermans Henk P.J. , Goeman Jelle J. , Böhringer Stefan , Morreau Hans , Nitsche Ulrich , Janssen Klaus-Peter , van de Velde Cornelis J.H. , Kuppen Peter J.K.
Published: April 2023

Supplementary File S7. Predicted target genes
Supplementary File S5 from MicroRNA Classifier and Nomogram for Metastasis Prediction in Colon Cancer
Authors: Goossens-Beumer Inès J. , Derr Remco S. , Buermans Henk P.J. , Goeman Jelle J. , Böhringer Stefan , Morreau Hans , Nitsche Ulrich , Janssen Klaus-Peter , van de Velde Cornelis J.H. , Kuppen Peter J.K.
Published: April 2023

Supplementary File S5. Associations of miRNA expression with clinicopathological parameters
Supplementary File S4 from MicroRNA Classifier and Nomogram for Metastasis Prediction in Colon Cancer
Authors: Goossens-Beumer Inès J. , Derr Remco S. , Buermans Henk P.J. , Goeman Jelle J. , Böhringer Stefan , Morreau Hans , Nitsche Ulrich , Janssen Klaus-Peter , van de Velde Cornelis J.H. , Kuppen Peter J.K.
Published: April 2023

Supplementary File S4. Reference miRNAs
Supplementary Figure 1 from Age-Group Differences in Human Papillomavirus Types and Cofactors for Cervical Intraepithelial Neoplasia 3 among Women Referred to Colposcopy
Authors: Gargano Julia W. , Nisenbaum Rosane , Lee Daisy R. , Ruffin IV Mack T. , Steinau Martin , Horowitz Ira R. , Flowers Lisa C. , Tadros Talaat S. , Birdsong George , Unger Elizabeth R.
Published: April 2023

PDf file - 38K
Supplementary Table 3 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
Authors: Khodr Zeina G. , Sherman Mark E. , Pfeiffer Ruth M. , Gierach Gretchen L. , Brinton Louise A. , Falk Roni T. , Patel Deesha A. , Linville Laura M. , Papathomas Daphne , Clare Susan E. , Visscher Daniel W. , Mies Carolyn , Hewitt Stephen M. , Storniolo Anna Maria V. , Rosebrock Adrian , Caban Jesus J. , Figueroa Jonine D.
Published: April 2023

Supplementary Table 3 - Associations between hormone levels and median TDLU span among women in the KTB.
Supplementary Table 1 from Methods for Sample Acquisition and Processing of Serial Blood and Tumor Biopsies for Multicenter Diffuse Large B-cell Lymphoma Clinical Trials
Authors: Nielsen Torsten Holm , Diaz Zuanel , Christodoulopoulos Rosa , Charbonneau Fredrick , Qureshi Samia , Rousseau Caroline , Benlimame Naciba , Camlioglu Errol , Constantin André Marc , Oros Kathleen Klein , Krumsiek Jan , Crump Michael , Morin Ryan D. , Cerchietti Leandro , Johnson Nathalie A. , Petrogiannis-Haliotis Tina , Miller Wilson H. , Assouline Sarit E. , Mann Koren K.
Published: April 2023

Contains quality control metrics from the Agilent microarrays.
Supplementary File 4 from Methods for Sample Acquisition and Processing of Serial Blood and Tumor Biopsies for Multicenter Diffuse Large B-cell Lymphoma Clinical Trials
Authors: Nielsen Torsten Holm , Diaz Zuanel , Christodoulopoulos Rosa , Charbonneau Fredrick , Qureshi Samia , Rousseau Caroline , Benlimame Naciba , Camlioglu Errol , Constantin André Marc , Oros Kathleen Klein , Krumsiek Jan , Crump Michael , Morin Ryan D. , Cerchietti Leandro , Johnson Nathalie A. , Petrogiannis-Haliotis Tina , Miller Wilson H. , Assouline Sarit E. , Mann Koren K.
Published: April 2023

Contains SOPs for collection and processing of peripheral blood.
Supplementary File 3 from Methods for Sample Acquisition and Processing of Serial Blood and Tumor Biopsies for Multicenter Diffuse Large B-cell Lymphoma Clinical Trials
Authors: Nielsen Torsten Holm , Diaz Zuanel , Christodoulopoulos Rosa , Charbonneau Fredrick , Qureshi Samia , Rousseau Caroline , Benlimame Naciba , Camlioglu Errol , Constantin André Marc , Oros Kathleen Klein , Krumsiek Jan , Crump Michael , Morin Ryan D. , Cerchietti Leandro , Johnson Nathalie A. , Petrogiannis-Haliotis Tina , Miller Wilson H. , Assouline Sarit E. , Mann Koren K.
Published: April 2023

Contains SOPs for isolation of DNA and RNA.
Supplementary Table 2 from Association of Mitotic Regulation Pathway Polymorphisms with Pancreatic Cancer Risk and Outcome
Authors: Couch Fergus J. , Wang Xianshu , Bamlet William R. , de Andrade Mariza , Petersen Gloria M. , McWilliams Robert R.
Published: April 2023

Supplementary Table 2 from Association of Mitotic Regulation Pathway Polymorphisms with Pancreatic Cancer Risk and Outcome
Supplementary Table S4 from Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
Authors: Kushekhar Kushi , van den Berg Anke , Nolte Ilja , Hepkema Bouke , Visser Lydia , Diepstra Arjan
Published: April 2023

Overview of genetic associations for classical Hodgkin lymphoma prognosis and treatment responses.
Supplementary Methods, Supplementary Figures 1-2, and Supplementary Tables 1-2. from Demand for Colonoscopy in Colorectal Cancer Screening Using a Quantitative Fecal Immunochemical Test and Age/Sex-Specific Thresholds for Test Positivity
Authors: Chen Sam Li-Sheng , Hsu Chen-Yang , Yen Amy Ming-Fang , Young Graeme P. , Chiu Sherry Yueh-Hsia , Fann Jean Ching-Yuan , Lee Yi-Chia , Chiu Han-Mo , Chiou Shu-Ti , Chen Hsiu-Hsi
Published: April 2023

Supplementary Information About Part I and Part II. Supplementary Figure S1. Study design for data collection and relating the hemoglobin concentration of FIT to CRC. Supplementary Figure S2. The relationships between the proportion of colonoscopy examination and sensitivity or specificity. Supplementary Table S1. Sensitivity and specificity of OC-sensor by different thresholds Supplementary Table S2. Age-/sex-specific quantity of colonoscopy by various methods
Supplementary figure 1. Supplementary tables 1-4 from Tonsillectomy and Incidence of Oropharyngeal Cancers
Authors: Chaturvedi Anil K. , Song Huan , Rosenberg Phillip S. , Ramqvist Torbjorn , Anderson William F. , Munck-Wikland Eva , Ye Weimin , Dalianis Tina
Published: April 2023

Supplemental Figure 1: Description of tonsillectomy cohort for the Swedish nation-wide study (1970-2009.)Supplemental Table 1: Clinical indications for tonsillectomy, stratified by calendar period and age at tonsillectomy. Supplemental Table 2: Clinical indications for tonsillectomies conducted as in-patient versus out-patient procedures (2006-2009.) Supplemental Table 3: Association of tonsillectomy with risk of head and neck cancers, stratified by age at tonsillectomy, gender, and calendar era of tonsillectomy.Supplemental Table 4: Sensitivity analyses of the association of tonsillectomy with risk of head and neck cancers.
Supplementary Figure 2 from CpG Site–Specific Hypermethylation of p16INK4α in Peripheral Blood Lymphocytes of PAH-Exposed Workers
Authors: Yang Ping , Ma Junxiang , Zhang Bo , Duan Huawei , He Zhini , Zeng Junling , Zeng Xiaowen , Li Daochuan , Wang Qing , Xiao Yongmei , Liu Caixia , Xiao Qin , Chen Liping , Zhu Xiaonian , Xing Xiumei , Li Zhifang , Zhang Shixin , Zhang Zhengbao , Ma Lu , Wang Erman , Zhuang Zhixiong , Zheng Yuxin , Chen Wen
Published: April 2023

PDF file - 293K
Supplementary Table 1 from Plasma Alkylresorcinol Metabolites as Biomarkers for Whole-Grain Intake and Their Association with Prostate Cancer: A Swedish Nested Case–Control Study
Authors: Drake Isabel , Sonestedt Emily , Gullberg Bo , Bjartell Anders , Olsson Håkan , Adlercreutz Herman , Tikkanen Matti J. , Wirfält Elisabet , Wallström Peter
Published: April 2023

PDF - 65K, Correlation coefficients between plasma DHBA and DHPPA, energy-adjusted dietary variables and body composition among 1817 male controls of a nested case-control study in the Malmoe Diet and Cancer cohort (1991-1996).
Supplementaty data from Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
Authors: Prizment Anna E. , Vierkant Robert A. , Smyrk Thomas C. , Tillmans Lori S. , Nelson Heather H. , Lynch Charles F. , Pengo Thomas , Thibodeau Stephen N. , Church Timothy R. , Cerhan James R. , Anderson Kristin E. , Limburg Paul J.
Published: April 2023

Supplementary Figure 1. Receiver operator curve (ROC) plots in the logistic regression model (Model 2) for all-cause (B) and CRC-death (A) within 5 years after diagnosis (adjusted for age of diagnosis, BMI, smoking status, stage and grade at diagnosis). AUC=area under the ROC curve. Supplementary Table 1. Characteristics of women diagnosed with CRC across tumor composite scores for cytotoxic T lymphocytes (CTL) and granzymeB (GZMB)a. Supplementary Table 2. Tumor stromal and epithelial cytotoxic T lymphocytes (CTL) scoresa and risk of all-cause and CRC-specific death in the CRC patients, IWHS, 1986-2011. Supplementary Table 3. Tumor stromal and epithelial granzyme B (GZMB) scores and risk of all-cause and CRC-specific death the CRC patients, IWHS, 1986-2011. Supplementary Table 4. Tumor composite scores for cytotoxic T lymphocytes (CTL) and granzyme B (GZMB) for all-cause and CRC-specific death in the CRC patients followed for 5 years, IWHS, 1986-2011.
Supplementary Table S4 from Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only
Authors: Cheung Yin Ting , Edelmann Michelle N. , Mulrooney Daniel A. , Green Daniel M. , Chemaitilly Wassim , John Neena , Robison Leslie L. , Hudson Melissa M. , Krull Kevin R.
Published: April 2023

Supplementary Table S4: Treatment Variables and Uric Acid in Adolescent Survivors Description: Within adolescent survivors, higher cumulative dose of daunorubicin was marginally associated with higher uric acid levels. After adjusting for gender and age, higher uric acid level in survivors was associated with higher homocysteine levels following high-dose methotrexate.
Supplementary Table S2 from Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only
Authors: Cheung Yin Ting , Edelmann Michelle N. , Mulrooney Daniel A. , Green Daniel M. , Chemaitilly Wassim , John Neena , Robison Leslie L. , Hudson Melissa M. , Krull Kevin R.
Published: April 2023

Supplementary Table S2: Definition of Cardiovascular Risk Factors Description: For the adult survivors, cardiovascular conditions were graded using the Common Terminology Criteria for Adverse Events version 4.03. Risk factors of interest were hypertension, dyslipidemia, abdominal obesity, high blood glucose, as well as overall metabolic syndrome.
Supplementary Fig. S1 from Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only
Authors: Cheung Yin Ting , Edelmann Michelle N. , Mulrooney Daniel A. , Green Daniel M. , Chemaitilly Wassim , John Neena , Robison Leslie L. , Hudson Melissa M. , Krull Kevin R.
Published: April 2023

Supplementary Fig. S1: Study Schema This figure summarizes the study design and objectives of this study.
Supplementary Material from Inflammatory-Related Genetic Variants in Non–Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment
Authors: Masson-Lecomte Alexandra , López de Maturana Evangelina , Goddard Michael E. , Picornell Antoni , Rava Marta , González-Neira Anna , Márquez Mirari , Carrato Alfredo , Tardon Adonina , Lloreta Josep , Garcia-Closas Montserrat , Silverman Debra , Rothman Nathaniel , Kogevinas Manolis , Allory Yves , Chanock Stephen J. , Real Francisco X. , Malats Núria
Published: April 2023

Supplementary methods, tables and figures
Supplementary Figures S1 - S5 from Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen
Authors: Nyante Sarah J. , Sherman Mark E. , Pfeiffer Ruth M. , de Gonzalez Amy Berrington , Brinton Louise A. , Bowles Erin J. Aiello , Hoover Robert N. , Glass Andrew , Gierach Gretchen L.
Published: April 2023

Supplementary Figure S1. Percent density from baseline to T5 is shown for each individual patient. Supplementary Figure S2. Percent density from baseline to T5 and change in density compared to the previous mammogram at T1 to T5. Supplementary Figure S3. Percent density from baseline to T5. Supplementary Figure S4. Percent density from baseline to T5 and change in density compared to the previous mammogram at T1 to T5. Supplementary Figure S5. Percent density from baseline to T5 and change in density compared to the previous mammogram at T1 to T5
Supplemental Table 2 from Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium
Authors: Cheng Iona , Shariff-Marco Salma , Koo Jocelyn , Monroe Kristine R. , Yang Juan , John Esther M. , Kurian Allison W. , Kwan Marilyn L. , Henderson Brian E. , Bernstein Leslie , Lu Yani , Sposto Richard , Vigen Cheryl , Wu Anna H. , Gomez Scarlett Lin , Keegan Theresa H.M.
Published: April 2023

Supplemental Table 2. Neighborhood characteristics of the California Breast Cancer Survivorship Consortium by race/ethnicity.
Supplemental Table 4 from The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts
Authors: Okayama Hirokazu , Schetter Aaron J. , Ishigame Teruhide , Robles Ana I. , Kohno Takashi , Yokota Jun , Takenoshita Seiichi , Harris Curtis C.
Published: April 2023

Supplemental Table 4. Nine cohorts of stage I, lung squamous cell carcinoma patients
Supplementary Table 1 from A Genome-Wide Association Study of Renal Cell Carcinoma among African Americans
Authors: Purdue Mark P. , Ye Yuanqing , Wang Zhaoming , Colt Joanne S. , Schwartz Kendra L. , Davis Faith G. , Rothman Nathaniel , Chow Wong-Ho , Wu Xifeng , Chanock Stephen J.
Published: April 2023

PDF - 86K, NCI study associations with RCC for SNPs selected for replication: comparison of findings with vs. without model adjustment for PCA eigenvector.
Supplementary Fig S2 from Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
Authors: Allard Bertrand , Pommey Sandra , Smyth Mark J. , Stagg John
Published: April 2023

Supplementary Fig S2 - PDF file 36K, Figure S2. Monotherapy or combined therapy with anti-CD73 mAb requires CD8+ T cells
Supplementary Figure 4 from Clinical Monoclonal B Lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: A Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features
Authors: Morabito Fortunato , Mosca Laura , Cutrona Giovanna , Agnelli Luca , Tuana Giacomo , Ferracin Manuela , Zagatti Barbara , Lionetti Marta , Fabris Sonia , Maura Francesco , Matis Serena , Gentile Massimo , Vigna Ernesto , Colombo Monica , Massucco Carlotta , Recchia Anna Grazia , Bossio Sabrina , De Stefano Laura , Ilariucci Fiorella , Musolino Caterina , Molica Stefano , Di Raimondo Francesco , Cortelezzi Agostino , Tassone Pierfrancesco , Negrini Massimo , Monti Sara , Rossi Davide , Gaidano Gianluca , Ferrarini Manlio , Neri Antonino
Published: April 2023

PDF file - 64K, Supervised analysis comparing cMBL and Rai0-CLL samples. Haetmaps of the differentially expressed (A) gene and (B) miRNA. Information about IGHV mutational status ('+' = M, '-' = UM), CD38, ZAP-70, chromosome 12 trisomy, chromosome 17, 11, and 13 deletions ('+' = positive, '-' = negative) are included alongside the patient ID. In the legend bar: turquoise indicates Rai0-CLL and yellow cMBL samples, respectively. The color scale bar represents the relative gene expression changes normalized by the standard deviation, and the color changes in each row represent gene expression relative to the mean across the samples.
Supplementary Tables 1 - 2, Figures 1 - 2 from Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer
Authors: Jeselsohn Rinath , Yelensky Roman , Buchwalter Gilles , Frampton Garrett , Meric-Bernstam Funda , Gonzalez-Angulo Ana Maria , Ferrer-Lozano Jaime , Perez-Fidalgo Jose A. , Cristofanilli Massimo , Gómez Henry , Arteaga Carlos L. , Giltnane Jennifer , Balko Justin M. , Cronin Maureen T. , Jarosz Mirna , Sun James , Hawryluk Matthew , Lipson Doron , Otto Geoff , Ross Jeffrey S. , Dvir Addie , Soussan-Gutman Lior , Wolf Ido , Rubinek Tamar , Gilmore Lauren , Schnitt Stuart , Come Steven E. , Pusztai Lajos , Stephens Philip , Brown Myles , Miller Vincent A.
Published: April 2023

PDF file - 187K, Supplementary Table 1: Detailed demographic information of all patients with metastatic breast cancer, including cohorts LM+ and EM+. Supplementary Table 2: ESR1 variant sequence data details. Abbreviations: cvg, coverage, N/A, non-applicable. Supplementary Table 3: List of genes sequenced by captured next generation sequencing. Supplementary figure 1: Genomic profiles of primary and metastatic tumors. Genomic alterations were found in 32 genes in primary and metastatic ER+ breast cancers. Genes are listed from the most frequently altered to least altered gene. Supplementary figure 2: No change in WT and mutant ER activity across a wide range of E2 doses. Luciferase activity in 293T cells after co-transfection of the ERE-TK-Luc reporter vector along with WT-ER, Y537N or D538G and E2 stimulation using doses of E2 ranging from 0.01nM to 100nM or vehicle treatment.
Supplementary Figure S1. Lymphocyte counts from Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)
Authors: Slingluff Craig L. , Petroni Gina R. , Molhoek Kerrington R. , Brautigan David L. , Chianese-Bullock Kimberly A. , Shada Amber L. , Smolkin Mark E. , Olson Walter C. , Gaucher Alison , Chase Cheryl Murphy , Grosh William W. , Weiss Geoffrey R. , Wagenseller Aubrey G. , Olszanski Anthony J. , Martin Lainie , Shea Sofia M. , Erdag Gulsun , Ram Prahlad , Gershenwald Jeffrey E. , Weber Michael J.
Published: April 2023

Lymphocyte counts for all patients on study - detail
Supplementary Figure 3 from Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors
Authors: Centenera Margaret M. , Gillis Joanna L. , Hanson Adrienne R. , Jindal Shalini , Taylor Renea A. , Risbridger Gail P. , Sutherland Peter D. , Scher Howard I. , Raj Ganesh V. , Knudsen Karen E. , Yeadon Trina , Tilley Wayne D. , Butler Lisa M.
Published: April 2023

PDF file, 381KB, Representative images from live cell imaging of PC-3 prostate cancer cells cultured in medium containing vehicle, AUY922 or HSP990 for 24 hours using the Incucyte� Plus (Bucher Biotech, Basel Switzerland). Bar = 30�m.
Data Supplement from SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies
Authors: Deckert Jutta , Wetzel Marie-Cécile , Bartle Laura M. , Skaletskaya Anna , Goldmacher Victor S. , Vallée François , Zhou-Liu Qing , Ferrari Paul , Pouzieux Stéphanie , Lahoute Charlotte , Dumontet Charles , Plesa Adriana , Chiron Marielle , Lejeune Pascale , Chittenden Thomas , Park Peter U. , Blanc Véronique
Published: April 2023

Supplementary Figure S4. Overlay of CD38-SAR650984-Fab and CD38-HB7
Supplemental Figure S1 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
Authors: Gehrke Iris , Bouchard Eric D.J. , Beiggi Sara , Poeppl Armando G. , Johnston James B. , Gibson Spencer B. , Banerji Versha
Published: April 2023

Figure S1: Protein lysates from CLL cells (n=21), PBMCs (n=4) or purified B-cells (n=2) from control donors were subjected to immunoblotting. Band signal intensities were quantified by ImageJ software. Values were corrected for background and normalized to background-corrected densitometric values of pan-actin (ratio NAMPT/actin). For control PBMCs the upper band, representing the expected protein size for actin (Fig. 1A), was used for normalization. Unpaired student´s t-test was used to assess statistical significance. Ctrl: vehicle control
Supplementary Figures 1-5 from Preexisting MEK1P124 Mutations Diminish Response to BRAF Inhibitors in Metastatic Melanoma Patients
Authors: Carlino Matteo S. , Fung Carina , Shahheydari Hamideh , Todd Jason R. , Boyd Suzanah C. , Irvine Mal , Nagrial Adnan M. , Scolyer Richard A. , Kefford Richard F. , Long Georgina V. , Rizos Helen
Published: April 2023

Supplementary Figures 1-5. S1 MEK1 P124 variants activate ERK1/2; S2 MEK1P124Q diminishes BRAF inhibitor sensitivity; S3 Effect of MEK1 mutations on MAPK and PI3K pathway signaling; S4 Identification of MEK1P124Q variant in the SMU030 cell line; S5 Characterisation of melanoma cell lines.
Supplementary Figure 1 from Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies
Authors: Mao Yicheng , Triantafillou Georgia , Hertlein Erin , Towns William , Stefanovski Matthew , Mo Xiaokui , Jarjoura David , Phelps Mitch , Marcucci Guido , Lee Ly James , Goldenberg David M. , Lee Robert J. , Byrd John C. , Muthusamy Natarajan
Published: April 2023

PDF file - 60K, Serum cholesterol levels from mice treated with DEX and L-DEX
Related Article from The Quest for Self-Identity: Not All Cancer Stem Cells Are the Same
Authors: Hjelmeland Anita B. , Rich Jeremy N.
Published: April 2023

Related Article from The Quest for Self-Identity: Not All Cancer Stem Cells Are the Same
Figure S4 from Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers
Authors: Lombardi Anne J. , Hoskins Elizabeth E. , Foglesong Grant D. , Wikenheiser-Brokamp Kathryn A. , Wiesmüller Lisa , Hanenberg Helmut , Andreassen Paul R. , Jacobs Allison J. , Olson Susan B. , Keeble Winifred W. , Hays Laura E. , Wells Susanne I.
Published: April 2023

Figure S4. PARP inhibitor sensitivity of human and murine HNSCC cells
Supplementary Data from Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
Authors: Morris Michael J. , Rathkopf Dana E. , Novotny William , Gibbons Jacqueline A. , Peterson Amy C. , Khondker Zakaria , Ouatas Taoufik , Scher Howard I. , Fleming Mark T.
Published: April 2023

Supplemental Table 1. Reasons for docetaxel discontinuation Supplemental Figure 1. Safety and PK assessment schedule
Supplementary Figure Legends from A Surprising Cross-Species Conservation in the Genomic Landscape of Mouse and Human Oral Cancer Identifies a Transcriptional Signature Predicting Metastatic Disease
Authors: Onken Michael D. , Winkler Ashley E. , Kanchi Krishna-Latha , Chalivendra Varun , Law Jonathan H. , Rickert Charles G. , Kallogjeri Dorina , Judd Nancy P. , Dunn Gavin P. , Piccirillo Jay F. , Lewis James S. , Mardis Elaine R. , Uppaluri Ravindra
Published: April 2023

PDF file - 81KB
Supplementary Figure 2 from Mitochondrial Topoisomerase I (Top1mt) Is a Novel Limiting Factor of Doxorubicin Cardiotoxicity
Authors: Khiati Salim , Dalla Rosa Ilaria , Sourbier Carole , Ma Xuefei , Rao V. Ashutosh , Neckers Leonard M. , Zhang Hongliang , Pommier Yves
Published: April 2023

PDF file - 118KB, A, Representative Western blots of respiratory chain proteins from skeletal muscle (left panel) and heart tissue (right panel) after saline or DOX injections. Animals from similar litters were used for each condition. B, Complex IV, III, I protein quantification from Western blot of heart tissues. n = 5, *, p<0.05, and **, p<0.006, t tests.
Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
Authors: Oberthuer André , Juraeva Dilafruz , Hero Barbara , Volland Ruth , Sterz Carolina , Schmidt Rene , Faldum Andreas , Kahlert Yvonne , Engesser Anne , Asgharzadeh Shahab , Seeger Robert , Ohira Miki , Nakagawara Akira , Scaruffi Paola , Tonini Gian Paolo , Janoueix-Lerosey Isabelle , Delattre Olivier , Schleiermacher Gudrun , Vandesompele Jo , Speleman Frank , Noguera Rosa , Piqueras Marta , Bénard Jean , Valent Alexander , Avigad Smadar , Yaniv Isaac , Grundy Richard G. , Ortmann Monika , Shao Chunxuan , Schwab Manfred , Eils Roland , Simon Thorsten , Theissen Jessica , Berthold Frank , Westermann Frank , Brors Benedikt , Fischer Matthias
Published: April 2023

Supplementary Data 1. This supplementary data comprises a step-by-step description on how our gene-expression based classification models were generated and validated